Vaishali Pharma Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Vaishali Pharma Ltd is ₹ 7.73 as of 05 May 15:30 . The P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 yearsThe P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 yearsThe Market Cap of Vista Pharmaceuticals Ltd changed from ₹ 33.26 crore on March 2021 to ₹ 39.52 crore on March 2025 . This represents a CAGR of 3.51% over 5 years The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 .The Revenue of Vista Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 .The EBITDA of Vista Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 .The Net Profit of Vista Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

FAQs for the comparison of Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Vaishali Pharma Ltd or Vista Pharmaceuticals Ltd?

Market cap of Vaishali Pharma Ltd is 100 Cr while Market cap of Vista Pharmaceuticals Ltd is 49 Cr

What are the key factors driving the stock performance of Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd?

As of May 5, 2026, the Vaishali Pharma Ltd stock price is INR ₹7.73. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹7.98.

How do dividend payouts of Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Vaishali Pharma Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.